Skip to main content

Advertisement

SpringerLink
Log in

Serum homocysteine, asymmetric dimethyl arginine (ADMA) and other arginine–NO pathway metabolite levels in patients with psoriasis

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Hyperhomocysteinemia, a well-known and independent risk factor for cardiovascular disease, has been related in several studies with psoriasis patients. It has been suggested that homocysteine leads to endothelial dysfunction by causing an accumulation of asymmetrical dimethyl arginine (ADMA), a potent endogenous nitric oxide (NO) synthase inhibitor of the l-arginine–NO pathway. However, limited data is available regarding the psoriasis and ADMA relationship. In this study, we aimed to investigate the serum levels of homocysteine, ADMA and other metabolites from the l-arginine–NO pathway in psoriasis patients. Forty-two patients with chronic plaque psoriasis and 48 controls were enrolled in the study. Serum homocysteine, ADMA, l-monomethyl-l-arginine (l-NMMA), symmetric dimethylarginine (SDMA) and l-arginine levels, and l-arginine/ADMA ratios of psoriasis patients and the control group were measured. The severity of psoriasis was assessed by the psoriasis area and severity index (PASI). The mean ADMA and homocysteine values were significantly higher, and citrulline and l-arginine/ADMA values were significantly lower in psoriasis patients compared to control subjects. However, there were no significant differences among the patient and control groups with respect to mean SDMA, l-NMMA and l-arginine values. PASI scores strongly correlated with the ADMA level and moderately correlated with l-arginine/ADMA ratio. This study suggests that the l-arginine–NO pathway metabolites, especially ADMA, may play an important role in the pathogenesis of psoriasis. Additionally, serum ADMA levels of psoriasis patients may be an indicator of the disease severity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Abeyakirthi S, Mowbray M, Bredenkamp N et al (2010) Arginase is overactive in psoriatic skin. Br J Dermatol 163:193–196

    CAS  PubMed  Google Scholar 

  2. Angel K, Provan SA, Mowinckel P et al (2012) The l-arginine/asymmetric dimethylarginine ratio is improved by anti-tumor necrosis factor-α therapy in inflammatory arthropathies. Associations with aortic stiffness. Atherosclerosis 225:160–165

    Article  CAS  PubMed  Google Scholar 

  3. Atzeni F, Sarzi-Puttini P, Sitia S et al (2011) Coronary flow reserve and asymmetric dimethylarginine levels: new measurements for identifying subclinical atherosclerosis in patients with psoriatic arthritis. J Rheumatol 38:1661–1664

    Article  CAS  PubMed  Google Scholar 

  4. Atzeni F, Turiel M, Boccassini L et al (2011) Cardiovascular involvement in psoriatic arthritis. Reumatismo 63:148–154

    Article  CAS  PubMed  Google Scholar 

  5. Bełtowski J, Kedra A (2006) Asymmetric dimethylarginine (ADMA) as a target for pharmacotherapy. Pharmacol Rep 58:159–178

    PubMed  Google Scholar 

  6. Brazzelli V, Grasso V, Fornara L et al (2010) Homocysteine, vitamin B12 and folic acid levels in psoriatic patients and correlation with disease severity. Int J Immunopathol Pharmacol 23:911–916

    CAS  PubMed  Google Scholar 

  7. Bruch-Gerharz D, Schnorr O, Suschek C et al (2003) Arginase 1 overexpression in psoriasis: limitation of inducible nitric oxide synthase activity as a molecular mechanism for keratinocyte hyperproliferation. Am J Pathol 162:203–211

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Cakmak SK, Gül U, Kiliç C et al (2009) Homocysteine, vitamin B12 and folic acid levels in psoriasis patients. J Eur Acad Dermatol Venereol 23:300–303

    Article  CAS  PubMed  Google Scholar 

  9. Di Gangi IM, Chiandetti L, Gucciardi A et al (2010) Simultaneous quantitative determination of N(G), N(G)-dimethyl-l-arginine or asymmetric dimethylarginine and related pathway’s metabolites in biological fluids by ultrahigh-performance liquid chromatography/electrospray ionization-tandem mass spectrometry. Anal Chim Acta 677:140–148

    Article  PubMed  Google Scholar 

  10. El-Mongy Fathy H, Abdelaziz A et al (2010) Subclinical atherosclerosis in patients with chronic psoriasis: a potential association. JEADV 24:661–666

    CAS  PubMed  Google Scholar 

  11. Erturan I, Köroğlu BK, Adiloğlu A et al (2014) Evaluation of serum sCD40L and homocysteine levels with subclinical atherosclerosis indicators in patients with psoriasis: a pilot study. Int J Dermatol 53:503–509

    Article  CAS  PubMed  Google Scholar 

  12. Krischel V, Bruch-Gerharz D, Suschek C et al (1998) Biphasic effect of exogenous nitric oxide on proliferation and differentiation in skin derived keratinocytes but not fibroblasts. J Invest Dermatol 111:286–291

    Article  CAS  PubMed  Google Scholar 

  13. Lentz SR, Rodionov RN, Dayal S (2003) Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA. Atheroscler Suppl 4:61–65

    Article  CAS  PubMed  Google Scholar 

  14. Liew SC, Das-Gupta E, Wong SF et al (2012) Association of methylentetraydrofolate reductase (MTHFR) 677 C>T gene polymorphism and homocysteine levels in psoriasis vulgaris patients from Malaysia: a case-control study. Nutr J 11:1

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Malerba M, Gisondi P, Radaeli A et al (2006) Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. Br J Dermatol 155:1165–1169

    Article  CAS  PubMed  Google Scholar 

  16. McDonald CJ, Calabresi P (1973) Thromboembolic disorders associated with psoriasis. Arch Dermatol 107:918

    Article  CAS  PubMed  Google Scholar 

  17. McDonald I, Connolly M, Tobin AM (2012) A review of psoriasis, a known risk factor for cardiovascular disease and its impact on folate and homocysteine metabolism. J Nutr Metab 2012:965385

    Article  PubMed Central  PubMed  Google Scholar 

  18. Nadar S, Blann AD, Lip GY (2004) Endothelial dysfunction: methods of assessment and application to hypertension. Curr Pharm Des 10:3591–3605

    Article  CAS  PubMed  Google Scholar 

  19. Naldi L, Mercuri SR (2010) Epidemiology of comorbidities in psoriasis. Dermatol Ther 23:114–118

    Article  PubMed  Google Scholar 

  20. Ormerod AD, Copeland P, Shah SA (2000) Treatment of psoriasis with topical NG-monomethyl-l-arginine, an inhibitor of nitric oxide synthesis. Br J Dermatol 142:985–990

    Article  CAS  PubMed  Google Scholar 

  21. Ozdemir O, Yakut A, Dinleyici EC (2011) Serum asymmetric dimethylarginine (ADMA), homocysteine, vitamin B(12), folate levels, and lipid profiles in epileptic children treated with valproic acid. Eur J Pediatr 170:873–877

    Article  CAS  PubMed  Google Scholar 

  22. Palomo I, Contreras A, Alarcón LM et al (2011) Elevated concentration of asymmetric dimethylarginine (ADMA) in individuals with metabolic syndrome. Nitric Oxide 24:224–228

    Article  CAS  PubMed  Google Scholar 

  23. Stanger O, Herrmann W, Pietrzik K et al (2003) DACH-LIGA Homocystein e.V. DACH-LIGA homocystein (German, Austrian and Swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 41:1392–1403

    CAS  PubMed  Google Scholar 

  24. Stühlinger MC, Tsao PS, Her JH et al (2001) Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation 104:2569–2575

    Article  PubMed  Google Scholar 

  25. Tobin AM, Hughes R, Hand EB et al (2011) Homocysteine status and cardiovascular risk factors in patients with psoriasis: a case-control study. Clin Exp Dermatol 36:19–23

    Article  PubMed  Google Scholar 

  26. Usta M, Yurdakul S, Aral H et al (2011) Vascular endothelial function assessed by a noninvasive ultrasound method and serum asymmetric dimethylarginine concentrations in mild-to-moderate plaque-type psoriatic patients. Clin Biochem 44:1080–1084

    Article  CAS  PubMed  Google Scholar 

  27. van der Zwan LP, Scheffer PG, Dekker JM et al (2011) Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavourable NOS substrate-to-inhibitor ratio: the Hoorn study. Clin Sci (Lond) 121:71–78

    Article  Google Scholar 

  28. van Guldener C, Nanayakkara PW, Stehouwer CD (2007) Homocysteine and asymmetric dimethylarginine (ADMA): biochemically linked but differently related to vascular disease in chronic kidney disease. Clin Chem Lab Med 45:1683–1687

    PubMed  Google Scholar 

  29. Vanizor Kural B, Orem A, Cimşit G et al (2003) Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients. Clin Chim Acta 332:23–30

    Article  CAS  PubMed  Google Scholar 

  30. Visser M, Paulus WJ, Vermeulen MA et al (2010) The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature. Eur J Heart Fail 12:1274–1281

    Article  CAS  PubMed  Google Scholar 

  31. Wang Tang WH, Cho L et al (2009) Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition. Arterioscler Thromb Vasc Biol 29:1383–1391

    Article  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant from the Scientific Research Project Coordination Unit of Selcuk University (Project No:  13401128).

Conflict of interest

This report does not have any conflict of interest.

Author information

Authors and Affiliations

  1. Department of Dermatology, School of Medicine, Selcuk University, Konya, Turkey

    Özlem Bilgiç & Hilmi Cevdet Altınyazar

  2. Department of Biochemistry, School of Medicine, Selcuk University, Konya, Turkey

    Hatice Baran & Ali Ünlü

  3. Deri ve Zührevi Hastalıklar Anabilim Dalı, Selçuk Üniversitesi Tıp Fakültesi Hastanesi, Alaeddin Keykubad Kampüsü, 42075, Selçuklu, Konya, Turkey

    Özlem Bilgiç

Authors
  1. Özlem Bilgiç
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hilmi Cevdet Altınyazar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hatice Baran
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ali Ünlü
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Özlem Bilgiç.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bilgiç, Ö., Altınyazar, H.C., Baran, H. et al. Serum homocysteine, asymmetric dimethyl arginine (ADMA) and other arginine–NO pathway metabolite levels in patients with psoriasis. Arch Dermatol Res 307, 439–444 (2015). https://doi.org/10.1007/s00403-015-1553-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-015-1553-3

Keywords

Search

Navigation